(42 days)
The CAREO Safety Syringe 1cc/mL is a sterile, single-use, disposable and non-reusable, retractable safety syringe which is intended to provide a safe and reliable method for intramuscular and subcutaneous injection of medication into a patient.
The CARFO Safety Syringe 1cc/mL is also intended to prevent needlestick injuries. In addition, when the user breaks the plunger, reuse of the syringe is prevented.
The Life-Shield Products, Inc., CAREO Safety Syringe 1cc/mL is a sterile, single use and disposable, 1cc/mL piston syringe, provided with a permanently attached needle in fifteen product configurations. The CAREO Safety Syringe 1cc/mL is similar in appearance, size, materials operation, and purpose to the cited predicate device and other conventional single use, sterile, disposable syringes.
The provided text describes a medical device (CAREO Safety Syringe 1cc/mL) seeking 510(k) premarket notification. The filing focuses on demonstrating substantial equivalence to predicate devices rather than proving performance against specific acceptance criteria through a dedicated study. Therefore, much of the requested information about acceptance criteria, study details, and AI-specific aspects (MRMC, standalone algorithm) is not applicable or cannot be extracted from this document.
Here's a breakdown of the information that can be extracted or inferred:
1. Table of Acceptance Criteria and Reported Device Performance:
The document does not present a formal table of acceptance criteria with corresponding performance metrics. Instead, it relies on demonstrating substantial equivalence to predicate devices. The "performance" is implicitly deemed acceptable if it is equivalent to the legally marketed predicate devices.
| Acceptance Criteria Category | Specific Acceptance Criteria (Inferred from Substantial Equivalence Basis) | Reported Device Performance |
|---|---|---|
| Biocompatibility | Device materials are biocompatible (e.g., non-toxic, non-irritating, non-sensitizing). | Testing provided in the premarket notification includes biocompatibility. (Specific results not detailed in this excerpt). |
| Packaging Integrity | Packaging maintains sterility and integrity until use. | Testing provided in the premarket notification includes packaging integrity. (Specific results not detailed in this excerpt). |
| Standards Conformity | Device conforms to relevant industry standards (not specified, but implicit for medical devices). | Testing provided in the premarket notification includes standards conformity. (Specific results not detailed in this excerpt). |
| Simulated Use Performance (Safety Syringe Functionality) | Device performs its intended functions for intramuscular and subcutaneous injection, prevents needlestick injuries, and prevents reuse after plunger breakage, similar to predicate devices. | "Simulated use testing has demonstrates that the CAREO Safety Syringe performs according to specification." |
| Equivalence to Predicate | The CAREO Safety Syringe 1cc/mL exhibits similar performance, safety, and effectiveness to its predicate devices for its stated intended use. | "Side-by-side testing of the CAREO Safety Syringe 1cc/mL and the 1cc SafePro* Safety Syringe shows that the two products are equivalent." |
| Indications for Use Support | Testing supports the claimed indications for use. | "Testing also supports the claimed Indications for Use." |
2. Sample size used for the test set and the data provenance:
- Sample size for the test set: Not explicitly stated. The document mentions "Side-by-side testing of the CAREO Safety Syringe Icc/mL and the 1cc SafePro* Safety Syringe" and "Simulated use testing," but does not specify the number of syringes or tests conducted.
- Data provenance: Not explicitly stated. It is implied that the testing was conducted by or for Life-Shield Products, Inc. (Taiwan, R.O.C.). The nature of the testing (simulated use, side-by-side comparison) suggests it would be prospective data collection for the purpose of this submission.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Number of experts: Not applicable. This type of device (a syringe) typically does not involve expert-reviewed "ground truth" in the way an imaging diagnostic device would. Performance is assessed through engineering tests and simulated use.
- Qualifications of experts: Not applicable.
4. Adjudication method for the test set:
- Adjudication method: Not applicable. As there are no "experts" establishing a subjective ground truth, there is no need for an adjudication method like 2+1 or 3+1. Performance is based on objective measurements and observations during testing.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- MRMC study: No. This is a physical medical device (syringe), not an AI diagnostic tool. Therefore, an MRMC comparative effectiveness study involving human readers and AI assistance is not applicable.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Standalone algorithm performance: No. This is a physical medical device, not an algorithm.
7. The type of ground truth used:
- Type of ground truth: Not applicable in the context of expert consensus or pathology for diagnostic interpretation. For this device, the "ground truth" for performance is established by objective engineering specifications, observed mechanical functionality in simulated use, and compliance with relevant standards. The primary "ground truth" for regulatory approval is the performance and characteristics of the legally marketed predicate devices, against which substantial equivalence is claimed.
8. The sample size for the training set:
- Sample size for the training set: Not applicable. This document does not describe the development or training of an AI algorithm; it is for a physical medical device.
9. How the ground truth for the training set was established:
- Ground truth for the training set: Not applicable.
{0}------------------------------------------------
MAR 1 0 2006
l of 2
510(k) Premarket Notification for the Life-Shield Products, Inc. CAREO Safety Syringe 1cc/mL (per 21 CFR807.92)
1. Sponsor
| Life-Shield Products, Inc. | |
|---|---|
| 3Fl., No. 10, Wuchiuan 7th Rd., | |
| Wugu Industrial Park, | |
| Taipei 248 | |
| Taiwan, R.O.C. | |
| Contact Person: | Mr. Hsiao, Chung-Chih |
| Telephone: | +886 2 2299 6033 |
Date Prepared: January 26, 2006
2. Device Name
| Proprietary Name: | CAREO Safety Syringe 1cc/mL |
|---|---|
| Common/Usual Name: | Hypodermic Syringe (with needle) |
| Classification Name: | Piston syringeHypodermic single lumen needle |
3. Predicate Device
4. Device Description
The Life-Shield Products, Inc., CAREO Safety Syringe 1cc/mL is a sterile, single use and disposable, 1cc/mL piston syringe, provided with a permanently attached needle in fifteen product configurations. The CAREO Safety Syringe 1cc/mL is similar in appearance, size, materials operation, and purpose to the cited predicate device and other conventional single use, sterile, disposable syringes.
Appendix Q - page 1
January 26, 2006
{1}------------------------------------------------
Intended Use 5.
The CAREO Safety Syringe 1cc/mL is a sterile, single-use, disposable and non-reusable, retractable safety syringe which is intended to provide a safe and reliable method for intramuscular and subcutaneous injection of medication into a patient.
The CARFO Safety Syringe 1cc/mL is also intended to prevent needlestick injuries. In addition, when the user breaks the plunger, reuse of the syringe is prevented.
6. Technological Characteristics and Substantial Equivalence
Life-Shield Products, Inc., makes a claim of substantial cquivalence of the CAREO Safety Syringe 1cc/mL to the 1cc SafePro* Safety Syringe (K022063) and CAREO Safety Syringe (3cc/mL, 5cc/mL, 10cc/mL) (K052397) based on similarities in intended use, design, technological and operational characteristics. All are indicated for injecting fluids into the body, while helping to reduce the risk of sharps injuries. All syringes are piston syringes that use permanently attached single lumen hypodermic needles. All syringes are provided sterile, single-use, and disposable. All syringes require the user to manually retract the needle-plunger into the syringe barrel, snap off the plunger rod, and discard the pieces.
7. Testing
Testing provided in this premarket notification includes biocompatibility, packaging integrity, standards conformity, and simulated use testing. Side-by-side testing of the CAREO Safety Syringe Icc/mL and the 1cc SafePro* Safety Syringe shows that the two products are equivalent. Simulated use testing has demonstrates that the CAREO Safety Syringe performs according to specification. Testing also supports the claimed Indications for Use.
Appendix Q - page 2
Life-Shield Products, Inc., Special 510(k) CAREO Safety Syringe 1cc/mL
January 26, 2006
CONFIDENTIAL
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" around the perimeter. Inside the circle is an abstract symbol that resembles three human profiles facing to the right.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 1 0 2006
Mr. Chung-Chih Hsiao Senior Regulatory Affairs Consultant Life-Shield Products, Incorporated 3F, No. 10 & 12, Wuchiuan 7th Rd. Wugu Industrial Park Taipei, Taiwan 248 Republic of China
Re: K060208
Trade/Device Name: CAREO Safety Syringe 1 CC/ML Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: II Product Code: MEG Dated: January 26, 2006 Received: February 8, 2006
Dear Mr. Hsiao:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 -- Mr. Chung-Chih Hsiao
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Sydie Y. M. chae Ond.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital , Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications For Use
510(k) Number (if known):__K060208
Device Name:_Life-Shield Products, Inc., CAREO Safety Syringe 1cc/mL
Indications For Use:
The CAREO Safety Syringe 1cc/mL is a sterile, single-use, disposable and non-The CARLO Salery Syringe Toomie is intended to provide a safe and reliable reduable, Tetractable Baret) Symrge injection of medication into patient.
The CAREO Safety Syringe 1cc/mL is also intended to prevent needlestick injuries. In The OARCO Outley offinge is the plunger, reuse of the syringe is prevented
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Cinta Keter
General Hospilli O Dental Devices
Page 1 of
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).